Litcius/Paper detail

A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database

Niti M. Patel, Britney A. Stottlemyer, Matthew P. Gray, Richard D. Boyce, Sandra L. Kane‐Gill

2021Cardiovascular Drugs and Therapy30 citationsDOI

Topics & Concepts

MedicineAdverse Event Reporting SystemPharmacovigilanceAdverse effectPostmarketing surveillanceMedDRADabigatranInternal medicineFebuxostatIntensive care medicineWarfarinAtrial fibrillationHyperuricemiaUric acidPharmacovigilance and Adverse Drug ReactionsAtrial Fibrillation Management and OutcomesCardiac electrophysiology and arrhythmias
A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database | Litcius